Source comparison
Follistatin-344 vs MK-677 — Key Research Differences
Research into muscle growth pathways has produced two compounds that appear in the same conversations but work through entirely different mechanisms: Follistatin-344, a myostatin antagonist that removes growth inhibition, and MK-677 (ibutamoren), a ghrelin rec
This comparison does not assign a generated winner or score.
- Research into muscle growth pathways has produced two compounds that appear in the same conversations but work through entirely different mechanisms: Follistatin-344, a myostatin antagonist that removes growth inhibition, and MK-677 (ibutamoren), a ghrelin receptor agonist that stimulates pulsatile growth hormone release. The difference between Follistatin-344 and MK-677 isn't subtle. It's foundational. Follistatin-344 binds directly to myostatin and activin A, proteins that actively suppress muscle cell proliferation, effectively releasing the metabolic brake on skeletal muscle hypertrophy. MK-677 triggers growth hormone secretion from the anterior pituitary by mimicking ghrelin, the hunger hormone, which then cascades into IGF-1 elevation and downstream anabolic signalling.
- Our team at Real Peptides has synthesised both compounds for research applications across hundreds of biological studies. The pattern we see consistently: researchers choosing Follistatin-344 are investigating muscle wasting pathways and genetic growth limitation models, while those selecting MK-677 are examining GH pulse frequency, sleep architecture effects, and indirect anabolic signalling through the IGF-1 axis.
- What is the difference between Follistatin-344 and MK-677?
- Follistatin-344 is a glycoprotein that binds and neutralises myostatin, a TGF-beta superfamily member that limits muscle growth. Administered locally via intramuscular injection at research doses of 100–500 mcg per site. MK-677 is an orally bioavailable growth hormone secretagogue that elevates endogenous GH and IGF-1 levels by 60–127% in clinical studies, typically dosed at 10–25mg daily. The difference between Follistatin-344 and MK-677 lies in their mechanisms: one removes inhibition, the other stimulates production.
- The confusion stems from overlapping research goals. Both compounds appear in muscle growth studies. But the biological pathways couldn't be more distinct. Follistatin-344 works at the tissue level, binding myostatin before it can attach to ActRIIB receptors on muscle satellite cells. MK-677 works systemically through the hypothalamic-pituitary axis, triggering coordinated hormone release that affects multiple tissues simultaneously. This article covers the structural differences between these compounds, their distinct pharmacokinetics, the specific research applications where each excels, and the preparation protocols that differ entirely between a protein therapeutic and a small-molecule secretagogue.